Hikma’s Darwazah Calls for Joint Production Partnerships at Jordan-EU Conference
19/11/2026 | 15:33:32
Amman, Nov. 19 (Petra) -- Jordan serves as a strategic gateway for European companies seeking to expand across regional markets, Hikma Pharmaceuticals Executive vice chairman and deputy CEO MENA Mazen Darwazah said.
Speaking during the Jordan-EU Investment Conference in the Dead Sea area, Darwazah called for moving beyond traditional trade toward long-term production partnerships built on joint investment, technology transfer, and manufacturing.
He said Jordanian companies possess the competitive advantages and accumulated expertise to act as a single operational partner for Europe across the entire Middle East and North Africa (MENA) region. By manufacturing, registering, and marketing European products, local firms spare European investors the burden of navigating and meeting the requirements of each regional market separately, he added.
Darwazah noted that Jordan’s competitiveness rests on stability, developed infrastructure, a network of trade agreements, and a connected geographic location, alongside a young, educated, multilingual workforce that adds roughly 90,000 graduates annually at competitive operating costs suited to regional hubs and shared services.
Jordanian industrial sectors have demonstrated exceptional resilience in maintaining supply chain sustainability and securing medicines through crises since the late 1970s up to the COVID-19 pandemic, he said.
He pointed to promising integration opportunities with European partners across high-value-added manufacturing, energy, infrastructure, information and communications technology, and apparel.
Darwazah underscored the importance of moving up the value chain by localizing research and development as well as advanced pharmaceutical manufacturing in the Kingdom, covering specialty drugs, biosimilars, and active pharmaceutical ingredients, in line with Economic Modernization Vision targets.
The Jordan-EU partnership represents a two-way complementary equation in which Europe brings technology and scale while Jordan provides market access, regulatory expertise, and human talent to generate sustainable jobs and shared growth, he said.
Founded in Jordan in 1978, Hikma provides high-quality medicines to those who need them and now operates globally with a local presence in North America, MENA, and Europe. It offers a broad portfolio of branded and non-branded generics and works to attract and deploy innovative healthcare technologies worldwide.
//Petra// NQ